These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17574575)

  • 1. Peptide aptamers expressed in the secretory pathway interfere with cellular PrPSc formation.
    Gilch S; Kehler C; Schätzl HM
    J Mol Biol; 2007 Aug; 371(2):362-73. PubMed ID: 17574575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
    Gilch S; Nunziante M; Ertmer A; Schätzl HM
    Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition.
    Borghouts C; Kunz C; Delis N; Groner B
    Mol Cancer Res; 2008 Feb; 6(2):267-81. PubMed ID: 18314488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion-protein-specific aptamer reduces PrPSc formation.
    Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
    Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of possible prion protein self-interaction domains using peptide arrays.
    Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
    BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity.
    Vetrugno V; Cardinale A; Filesi I; Mattei S; Sy MS; Pocchiari M; Biocca S
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1791-7. PubMed ID: 16288721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamers against prion proteins and prions.
    Gilch S; Schätzl HM
    Cell Mol Life Sci; 2009 Aug; 66(15):2445-55. PubMed ID: 19396399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection of RNA aptamers against cellular and abnormal isoform of mouse prion protein.
    Sekiya S; Nishikawa F; Noda K; Kumar PK; Yokoyama T; Nishikawa S
    Nucleic Acids Symp Ser (Oxf); 2005; (49):361-2. PubMed ID: 17150783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation.
    Iwamaru Y; Shimizu Y; Imamura M; Murayama Y; Endo R; Tagawa Y; Ushiki-Kaku Y; Takenouchi T; Kitani H; Mohri S; Yokoyama T; Okada H
    J Neurochem; 2008 Nov; 107(3):636-46. PubMed ID: 18717818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Peptide Aptamers with Prion Protein Central Domain Promotes α-Cleavage of PrP
    Corda E; Du X; Shim SY; Klein AN; Siltberg-Liberles J; Gilch S
    Mol Neurobiol; 2018 Oct; 55(10):7758-7774. PubMed ID: 29460268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication.
    Bate C; Tayebi M; Williams A
    Biochem J; 2010 Apr; 428(1):95-101. PubMed ID: 20196773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
    Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and characterisation of fully posttranslationally modified cellular prion protein in Pichia pastoris.
    Marbach J; Zentis P; Ellinger P; Müller H; Birkmann E
    Biol Chem; 2013 Nov; 394(11):1475-83. PubMed ID: 23893688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of Peptide aptamers to target protein function.
    Lopez-Ochoa L; Nash TE; Ramirez-Prado J; Hanley-Bowdoin L
    Methods Mol Biol; 2009; 535():333-60. PubMed ID: 19377987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures.
    Bickle MB; Dusserre E; Moncorgé O; Bottin H; Colas P
    Nat Protoc; 2006; 1(3):1066-91. PubMed ID: 17406388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide aptamers as guides for small-molecule drug discovery.
    Baines IC; Colas P
    Drug Discov Today; 2006 Apr; 11(7-8):334-41. PubMed ID: 16580975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semisynthesis of membrane-attached prion proteins.
    Chu NK; Becker CF
    Methods Enzymol; 2009; 462():177-93. PubMed ID: 19632475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation.
    Cardinale A; Filesi I; Vetrugno V; Pocchiari M; Sy MS; Biocca S
    J Biol Chem; 2005 Jan; 280(1):685-94. PubMed ID: 15513919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.